BRPI0924013A2 - método para o exame de câncer - Google Patents
método para o exame de câncerInfo
- Publication number
- BRPI0924013A2 BRPI0924013A2 BRPI0924013A BRPI0924013A BRPI0924013A2 BR PI0924013 A2 BRPI0924013 A2 BR PI0924013A2 BR PI0924013 A BRPI0924013 A BR PI0924013A BR PI0924013 A BRPI0924013 A BR PI0924013A BR PI0924013 A2 BRPI0924013 A2 BR PI0924013A2
- Authority
- BR
- Brazil
- Prior art keywords
- cancer screening
- cancer
- screening
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57535—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the large intestine, e.g. colon, rectum or anus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2537/00—Reactions characterised by the reaction format or use of a specific feature
- C12Q2537/10—Reactions characterised by the reaction format or use of a specific feature the purpose or use of
- C12Q2537/164—Methylation detection other then bisulfite or methylation sensitive restriction endonucleases
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/154—Methylation markers
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Pathology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Biomedical Technology (AREA)
- Hospice & Palliative Care (AREA)
- Urology & Nephrology (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/CN2009/000411 WO2010118559A1 (zh) | 2009-04-17 | 2009-04-17 | 一种癌症筛检的方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0924013A2 true BRPI0924013A2 (pt) | 2015-11-24 |
Family
ID=42982108
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0924013A BRPI0924013A2 (pt) | 2009-04-17 | 2009-04-17 | método para o exame de câncer |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP2420578B1 (pt) |
| JP (1) | JP6043185B2 (pt) |
| KR (2) | KR101530498B1 (pt) |
| AU (1) | AU2009344468B2 (pt) |
| BR (1) | BRPI0924013A2 (pt) |
| CA (1) | CA2758437C (pt) |
| DK (1) | DK2420578T3 (pt) |
| ES (1) | ES2638294T3 (pt) |
| IL (1) | IL215669A0 (pt) |
| NZ (1) | NZ595640A (pt) |
| SG (1) | SG175183A1 (pt) |
| WO (1) | WO2010118559A1 (pt) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101385783B1 (ko) * | 2012-06-25 | 2014-04-16 | 가톨릭대학교 산학협력단 | 간암 진단 마커 및 치료제로서의 dbc1 |
| JP2016201999A (ja) * | 2013-08-26 | 2016-12-08 | 北海道公立大学法人 札幌医科大学 | 大腸癌を検出する方法 |
| WO2017040491A1 (en) | 2015-08-31 | 2017-03-09 | The United States Of America As Represented By The Secretary Of The Army | Methods for molecularly characterizing cervical cell samples |
| US11932909B2 (en) * | 2017-03-10 | 2024-03-19 | Self-Screen B.V. | Methylation classifier for detection of HPV-induced invasive cancers, nonHPV-induced gynaecological and anogenital cancers and their high-grade precursor lesions |
| CN109468381B (zh) * | 2018-11-19 | 2022-11-25 | 兰州市第一人民医院 | 用于宫颈癌筛查的甲基化位点及其检测引物 |
| US11001898B2 (en) | 2019-05-31 | 2021-05-11 | Universal Diagnostics, S.L. | Detection of colorectal cancer |
| US11396679B2 (en) | 2019-05-31 | 2022-07-26 | Universal Diagnostics, S.L. | Detection of colorectal cancer |
| US11898199B2 (en) | 2019-11-11 | 2024-02-13 | Universal Diagnostics, S.A. | Detection of colorectal cancer and/or advanced adenomas |
| WO2021228418A1 (en) | 2020-05-15 | 2021-11-18 | Universal Diagnostics, S.L. | Methods and systems for identifying methylation biomarkers |
| GB202009220D0 (en) * | 2020-06-17 | 2020-07-29 | Ucl Business Ltd | Methods for detecting and predicting cancer |
| US11530453B2 (en) | 2020-06-30 | 2022-12-20 | Universal Diagnostics, S.L. | Systems and methods for detection of multiple cancer types |
| CN114561461B (zh) * | 2020-11-27 | 2024-01-30 | 广州达健生物科技有限公司 | 用于检测宫颈癌的组合物及其试剂盒和应用 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE373673T1 (de) * | 2003-01-29 | 2007-10-15 | Hoffmann La Roche | Verbessertes verfahren zur behandlung durch bisulfit |
| GB0413688D0 (en) * | 2004-06-18 | 2004-07-21 | Novartis Forschungsstiftung | Analysis of methylated nucleic acid |
| CA2639070A1 (en) * | 2006-04-13 | 2007-11-01 | Oncomethylime Sciences S.A. | Novel tumour suppressor |
| TW200831900A (en) | 2007-01-23 | 2008-08-01 | Hong-Zheng Lai | Cancer screen method |
| US7820386B2 (en) | 2007-06-15 | 2010-10-26 | National Defense Medical Center | Cancer screening method |
| CN101250588A (zh) * | 2008-04-09 | 2008-08-27 | 王道荣 | 一种利用粪便中sfrp2基因超甲基化筛查大肠癌的方法 |
-
2009
- 2009-04-17 DK DK09843193.5T patent/DK2420578T3/en active
- 2009-04-17 NZ NZ595640A patent/NZ595640A/en not_active IP Right Cessation
- 2009-04-17 WO PCT/CN2009/000411 patent/WO2010118559A1/zh not_active Ceased
- 2009-04-17 ES ES09843193T patent/ES2638294T3/es active Active
- 2009-04-17 AU AU2009344468A patent/AU2009344468B2/en not_active Ceased
- 2009-04-17 JP JP2012505025A patent/JP6043185B2/ja not_active Expired - Fee Related
- 2009-04-17 CA CA2758437A patent/CA2758437C/en active Active
- 2009-04-17 BR BRPI0924013A patent/BRPI0924013A2/pt not_active Application Discontinuation
- 2009-04-17 EP EP09843193.5A patent/EP2420578B1/en not_active Not-in-force
- 2009-04-17 KR KR1020147001198A patent/KR101530498B1/ko not_active Expired - Fee Related
- 2009-04-17 SG SG2011074275A patent/SG175183A1/en unknown
- 2009-04-17 KR KR1020117024476A patent/KR101636596B1/ko not_active Expired - Fee Related
-
2011
- 2011-10-10 IL IL215669A patent/IL215669A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2010118559A1 (zh) | 2010-10-21 |
| KR20120016201A (ko) | 2012-02-23 |
| JP2012523822A (ja) | 2012-10-11 |
| EP2420578A4 (en) | 2012-09-26 |
| SG175183A1 (en) | 2011-12-29 |
| KR101530498B1 (ko) | 2015-06-19 |
| KR101636596B1 (ko) | 2016-07-11 |
| DK2420578T3 (en) | 2017-10-02 |
| ES2638294T3 (es) | 2017-10-19 |
| AU2009344468B2 (en) | 2015-02-12 |
| CA2758437C (en) | 2018-10-09 |
| IL215669A0 (en) | 2012-01-31 |
| KR20140017704A (ko) | 2014-02-11 |
| JP6043185B2 (ja) | 2017-02-22 |
| CA2758437A1 (en) | 2010-10-21 |
| AU2009344468A1 (en) | 2011-11-03 |
| NZ595640A (en) | 2014-01-31 |
| EP2420578B1 (en) | 2017-06-14 |
| EP2420578A1 (en) | 2012-02-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0924013A2 (pt) | método para o exame de câncer | |
| BRPI1010766A2 (pt) | processo para rebaudiosídeo d | |
| BRPI1006075A2 (pt) | biomarcadores de cancer | |
| BR112012002746A2 (pt) | método para produção de copolímero | |
| BRPI0918550A2 (pt) | projeto de sinal de referência para lte avancada | |
| BR112012010958A2 (pt) | método para intensificação de feixe | |
| BR112012002335A2 (pt) | pigmento composto e método para preparação do mesmo | |
| BRPI1007459A2 (pt) | método para produção de manômeros olefínicos | |
| BRPI1009549A2 (pt) | aparelho para fabricação de estrutura de aeronave | |
| BRPI1012813A2 (pt) | aparelho e método para modelar projetos de poço e desempenho de poço | |
| BRPI1013618A2 (pt) | pirimidinas substituídas para o tratamento de câncer | |
| PT2484669E (pt) | Derivados de fenol | |
| BRPI0922490A2 (pt) | Método para produção de beta-santaleno | |
| PT2207037T (pt) | Método para a deteção de cancro | |
| BRPI1009919A2 (pt) | combinações de pentamidina para tratamento de câncer. | |
| BRPI1011791A2 (pt) | montagem para perfuração de fundo de poço | |
| BRPI0814406A2 (pt) | Método para produzir dimetacrilato de etileno glicol | |
| BRPI1011731A2 (pt) | dispositivo para produzir fechos | |
| BRPI1012529A2 (pt) | método para produção de sínter | |
| BRPI0818674A2 (pt) | Método para produção de anticorpos | |
| BRPI1009435A2 (pt) | tratamento para câncer no pâncreas | |
| PT2467140T (pt) | Lapatinib para tratamento do cancro | |
| BRPI1007320A2 (pt) | Método para preparar nitrotetrazolato de cobre | |
| BRPI0923370A2 (pt) | Método para produção de titanossilicato | |
| BRPI0918744A2 (pt) | Metodo para produção de açúcar |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B25A | Requested transfer of rights approved |
Owner name: NATIONAL DEFENSE MEDICAL CENTER (TW) |
|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B07G | Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette] | ||
| B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
| B11B | Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements |